Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

POAI - Predictive Oncology Inc.

Previous close
0.826
0.056   6.780%

Share volume: 700
Last Updated: Thu 26 Dec 2024 08:06:07 PM CET
Surgical and Medical Instrument Manufacturing : 1.09%

PREVIOUS CLOSE
CHG
CHG%
$0.77
0.06
7.27%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
13%
Profitability 25%
Dept financing 24%
Liquidity 11%
Performance 0%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
8.75%
1 Month
-6.75%
3 Months
-1.53%
6 Months
-29.62%
1 Year
-77.39%
2 Year
-99.45%
Key data
Stock price
$0.83
P/E Ratio 
0.00
DAY RANGE
$0.77 - $0.80
EPS 
$0.00
52 WEEK RANGE
$0.60 - $3.76
52 WEEK CHANGE
-$77.99
MARKET CAP 
6.374 M
YIELD 
N/A
SHARES OUTSTANDING 
6.667 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/12/2024
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$58,785
AVERAGE 30 VOLUME 
$93,782
Company detail
CEO: Raymond F. Vennare
Region: US
Website: predictive-oncology.com
Employees: 30
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Predictive Oncology Inc. focuses on developing personalized cancer therapies using artificial intelligence (AI) The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. It also offers research and development services; and media that help cancer cells grow outside the patient's body and retain their DNA/RNA and proteomic signatures.

Recent news